Thought of the Week: What We Give
July 17, 2025
Thought of the Week: They Invented Hugs
Related:
Thought of the Week: Dissolving the Pain
July 9, 2025
Thought of the Week: What I Can Do
July 1, 2025
Thought of the Week – Kindness Grows Abundant
June 17, 2025
As I Grow Older
June 11, 2025
Honoring Dad on Father’s Day
June 10, 2025
Edited by:
P. Berger
Caring for dementias such as Alzheimer's among family and friends, Peter committed to help preserve the dignity of people affected by Alzheimer's. AlzheimersWeekly.com is the fruit of that commitment.
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To
Dementia Books & Videos on Amazon:
More From Alzheimer's Weekly
Dementia Types
Telling L.A.T.E. Dementia & Alzheimer’s Apart
L.A.T.E.-Dementia is under-recognized, with a health impact as large as Alzheimer’s in very old people. It affects 25% of people over 85 and has nothing to do with the plaques and tangles that cause Alzheimer’s.
No Comments
Uncategorized
New Treatment for Chorea from Huntington’s Dementia
Join HDSA for a research webinar, discussing the new FDA-approved medication for treatment of chorea associated with HD in adults.
No Comments
Drugs
Ensuring Lecanemab Reaches Those Who Need It
Lecanemab (marketed as Leqembi) is today’s top Alzheimer’s drug. Why does equitable access to this drug remain a significant challenge? What needs to be done?
No Comments
Drugs
Kisunla Approved by FDA, 2nd Drug to Actually Slow Alzheimer’s
VIDEO + ARTICLE: Kisunla (generic name: Donanemab) slowed cognitive and functional decline 35%. Once-monthly infusions reduced Alzheimer’s plaque 84%.
No Comments
Share to Facebook
Twitter
LinkedIn
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On
One person said to me, “They know love. They know people who love them.” That says so much.
This comment has been removed by a blog administrator.